NCT05714553 2025-07-18
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
NuCana plc
Phase 1/2 Terminated
NuCana plc
City of Hope Medical Center
Drexel University
Taichung Veterans General Hospital
Dana-Farber Cancer Institute